Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders' Equity

v3.20.2
Condensed Consolidated Statements of Changes In Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning balance at Dec. 31, 2018 $ 8 $ 37,880 $ (35,067) $ 2,821
Beginning balance, shares at Dec. 31, 2018 7,481,723      
Proceeds from sale of common stock, net 211 211
Proceeds from sale of common stock, net, shares 111,129      
Proceeds from private placement of common stock $ 1 1,849 1,850
Proceeds from private placement of common stock, shares 1,267,123      
Issuance of common stock upon exchange of related party promissory note payable 250 250
Issuance of common stock upon exchange of related party promissory note payable, shares 171,233      
Stock-based compensation expense 93 93
Stock-based compensation expense, shares      
Issuance of restricted common stock 211 211
Issuance of restricted common stock, shares 145,700      
Net loss (3,071) (3,071)
Ending balance at Sep. 30, 2019 $ 9 40,494 (38,138) 2,365
Ending balance, shares at Sep. 30, 2019 9,176,908      
Beginning balance at Jun. 30, 2019 $ 9 40,462 (37,217) 3,254
Beginning balance, shares at Jun. 30, 2019 9,170,658      
Stock-based compensation expense 22 22
Stock-based compensation expense, shares      
Issuance of restricted common stock 10 10
Issuance of restricted common stock, shares 6,250      
Net loss (921) (921)
Ending balance at Sep. 30, 2019 $ 9 40,494 (38,138) 2,365
Ending balance, shares at Sep. 30, 2019 9,176,908      
Beginning balance at Dec. 31, 2019 $ 9 40,496 (39,325) 1,180
Beginning balance, shares at Dec. 31, 2019 9,176,908      
Proceeds from sale of common stock, net $ 1 1,202 1,203
Proceeds from sale of common stock, net, shares 964,102      
Proceeds from private placement of common stock $ 1 1,029 1,030
Proceeds from private placement of common stock, shares 851,240      
Issuance of common stock upon exchange of related party promissory note payable $ 1 824 825
Issuance of common stock upon exchange of related party promissory note payable, shares 681,818      
Stock-based compensation expense 27 27
Stock-based compensation expense, shares      
Issuance of restricted common stock 209 209
Issuance of restricted common stock, shares 172,727      
Net loss (2,452) (2,452)
Ending balance at Sep. 30, 2020 $ 12 43,787 (41,777) 2,022
Ending balance, shares at Sep. 30, 2020 11,846,795      
Beginning balance at Jun. 30, 2020 $ 12 43,778 (40,962) 2,828
Beginning balance, shares at Jun. 30, 2020 11,846,795      
Stock-based compensation expense 9 9
Net loss (815) (815)
Ending balance at Sep. 30, 2020 $ 12 $ 43,787 $ (41,777) $ 2,022
Ending balance, shares at Sep. 30, 2020 11,846,795